Core Viewpoint - The company, Qiming Medical, is divesting a minority stake in Valgen Holding Corporation to focus on its core business and improve financial flexibility through the sale of non-core investments [1] Group 1: Transaction Details - Qiming Medical (Hong Kong) Limited has entered into a share transfer agreement with Broncus China Holding Corporation to sell shares for a total consideration of $15 million, representing approximately 1.05% of the total issued shares of Valgen Holding Corporation as of the announcement date [1] - Valgen Holding Corporation is a Cayman Islands registered company primarily engaged in providing systemic solutions for mitral and tricuspid regurgitation [1] Group 2: Strategic Rationale - The company aims to reallocate resources to develop its core products and support long-term business growth by streamlining its investment portfolio [1] - The board believes that prudent capital management, including this divestment, will enhance the company's sustainable development and strengthen shareholder returns [1]
启明医疗-B拟1500万美元出售被投资公司Valgen Holding Corporation约1.05%股份